Drug Type Peptide drug conjugates |
Synonyms Tye 1317, Tye1317 |
Target |
Action inhibitors |
Mechanism CDK inhibitors(Cyclin-dependent kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Cancer | Discovery | China | 29 Jan 2024 |





